TLR4 and interstitial lung disease: It has been suggested that the activation of TLR4, a LPS receptor expressed on macrophages, may serve as a link between viral infection, inflammation and fibrosis, which are common features of interstitial lung disease (ILD) both idiopathic and associated with RA and COVID 19 (51).